Time to Resolution of Myelosuppression and Associated Hospitalization in Patients With Newly-Diagnosed Acute Myeloid Leukemia (AML) Treated With Ivosidenib (IVO) plus Azacitidine (AZA) Compared to Placebo (PBO) plus AZA

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览2
暂无评分
关键词
AML, ivosidenib, neutropenia, myelosuppression, hospitalization
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要